Compare SGHT & ESEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | ESEA |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.0M | 481.2M |
| IPO Year | 2021 | 2005 |
| Metric | SGHT | ESEA |
|---|---|---|
| Price | $4.97 | $70.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $9.08 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 335.9K | 43.7K |
| Earning Date | 05-06-2026 | 06-17-2026 |
| Dividend Yield | N/A | ★ 4.24% |
| EPS Growth | ★ 28.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $77,363,000.00 | N/A |
| Revenue This Year | $11.67 | $1.74 |
| Revenue Next Year | $10.39 | $1.07 |
| P/E Ratio | ★ N/A | $3.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.11 | $37.40 |
| 52 Week High | $9.24 | $74.76 |
| Indicator | SGHT | ESEA |
|---|---|---|
| Relative Strength Index (RSI) | 57.87 | 53.70 |
| Support Level | $4.86 | $51.63 |
| Resistance Level | $5.46 | $73.31 |
| Average True Range (ATR) | 0.41 | 3.21 |
| MACD | 0.04 | -0.31 |
| Stochastic Oscillator | 60.56 | 64.75 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.